Congenital Cytomegalovirus Infection
Moderna Halts Development of CMV Vaccine After Phase 3 Failure
Moderna; CMV vaccine; mRNA-1647; Phase 3 trial; Congenital cytomegalovirus; Vaccine efficacy; Clinical trial failure
Actionable Insights Powered by AI
Moderna; CMV vaccine; mRNA-1647; Phase 3 trial; Congenital cytomegalovirus; Vaccine efficacy; Clinical trial failure